The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Albendazole-induced associated acute hepatitis and bicytopenia
Abstract
Acute hepatitis induced by albendazole is rarely reported. We describe herein an original case of acute hepatitis associated with bicytopenia after albendazole intake. This paper is the first to describe a possible association of a hematologic disorder and acute hepatitis, both induced by albendazole therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most problems with albendazole are associated with higher dose treatment for systemic infections where drug-parasite interactions cause specific syndromes such as abnormal liver functions, central nervous system symptoms, or hematologic side effects.
“Most problems are associated with higher dose treatment for systemic infections where problems of drug-parasite interactions cause specific syndromes such as abnormal liver functions (for example, in echinococcosis), central nervous system symptoms (in neurocysticercosis), or hematologic side effects [53,308–312].”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [312]
Citations
Cites
Albendazole: a review of anthelmintic efficacy and safety in humans
HORTON, J. (2000) · Parasitology · doi:10.1017/s0031182000007290 · Cited by 386
Albendazole in hydatid disease—hepatocellular toxicity
Morris, D. L., & Smith, P. G. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90259-8 · Cited by 54
Albendazole-Induced Amegakaryocytic Thrombocytopenic Purpura
Yildiz, B. O., Haznedaroğlu, İ. C., & Çöplü, L. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17433 · Cited by 18
Flagged first, then by citations
Research works printed but not linked: 12
- Aggarwal P, 1991, Thorax, 46, 599, 10.1136/thx.46.8.599 · DOI
- Smego RA, 2003, Clin Infect Dis, 37, 1073, 10.1086/378275 · DOI · Paper page
- Teggi A, 1993, Antimicrob Agents Chemother, 37, 1679, 10.1128/AAC.37.8.1679 · DOI
- Polat C, 2005, J Gastroenterol Hepatol, 20, 421, 10.1111/j.1440-1746.2004.03535.x · DOI · Paper page
- Choi GY, 2008, J Korean Med Sci, 23, 903, 10.3346/jkms.2008.23.5.903 · DOI · Paper page
- Amoruso C, 2009, Pediatr Med Chir, 31, 262
- García-Cortés M, 2008, Aliment Pharmacol Ther, 27, 780, 10.1111/j.1365-2036.2008.03655.x · DOI · Paper page
- Khuroo MS, 1993, Gastroenterology, 104, 1452, 10.1016/0016-5085(93)90355-G · DOI
- Sekhon SS, 2006, South Med J, 99, 491, 10.1097/01.smj.0000209275.75045.d4 · DOI
- Opatrny L, 2005, Am J Trop Med Hyg, 72, 291, 10.4269/ajtmh.2005.72.291 · DOI
- Akbal E, 2008, Turk J Hematol, 25, 45
- Morris DL, 1985, JAMA, 253, 2053, 10.1001/jama.1985.03350380069023 · DOI
Cited by
Sorted by citations
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Metadata
- Authors
- Ben Fredj, N., Chaabane, A., Chadly, Z., Ben Fadhel, N., Boughattas, N. A., & Aouam, K.
- Affiliations
- University of Monastir (TN)
- Venue
- Scandinavian Journal of Infectious Diseases
- Publisher
- Informa UK Limited
- Published
- 2014-01-15
- Volume
- 46
- Issue
- 2
- Pages
- 149-151
- ISSN
- 0036-5548 (ISSN-L)
- 1651-1980
- OpenAlex
- W2070887222
- Cited by
- 22
- References
- 3
- Citations by year
- 2026: 2 · 2023: 5 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 3 · 2015: 4 · 2014: 3
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- albendazole, drug-induced liver injury, acute hepatitis, bicytopenia, hematologic adverse events, antiparasitic drug toxicity
- MeSH terms
- Adult, Anemia, Anthelmintics, Humans, Male, Thrombocytopenia, Albendazole, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
